Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_assertion description "[Pathological samples of SCLC also expressed IGFBP-2 abundantly, as compared with NSCLC, and showed only rare (8%) IGFBP-2 promoter methylation, whereas the IGFBP-2 promoter was methylated in 71% of adenocarcinomas and 29% of squamous cell carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_assertion evidence source_evidence_literature NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_assertion SIO_000772 19679880 NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_assertion wasDerivedFrom befree-20150227 NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_assertion wasGeneratedBy ECO_0000203 NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP484743.RAUrdkJ-eoCQXiuaah4HVCQRq8S4BSxrG8fKMNViiVGYk130_provenance.